China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
25 hedge funds and large institutions have $407M invested in China Biologic Products Holdings, Inc. in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
20% more capital invested
Capital invested by funds: $339M → $407M (+$68.1M)
14% more funds holding
Funds holding: 22 → 25 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
74% less call options, than puts
Call options by funds: $212K | Put options by funds: $813K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$381K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$353K |
| 3 |
NA
Navellier & Associates
Reno,
Nevada
|
+$200K |
| 4 |
VAM
Visium Asset Management
New York
|
+$149K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$80.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$926K |
| 2 |
Invesco
Atlanta,
Georgia
|
-$422K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$363K |
| 4 |
Two Sigma Investments
New York
|
-$237K |
| 5 |
SIM
Spark Investment Management
New York
|
-$194K |
CBPO Hedge Fund Activity: Q1 2014 in Review
25 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q1 2014, worth a combined $407M — up 20% from $339M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CBPO positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 10 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $381K. The largest seller was BlackRock Institutional Trust, cutting an estimated $926K.
- 25 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q1 2014, up from 22 in Q4 2013.
- Funds reported $407M of China Biologic Products Holdings, Inc. stock for Q1 2014, up 20% quarter-over-quarter.
- 4 funds opened new China Biologic Products Holdings, Inc. positions in Q1 2014 and 1 closed out, a net change of +3 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q1 2014 was Renaissance Technologies, an estimated $381K added.
- The largest China Biologic Products Holdings, Inc. seller in Q1 2014 was BlackRock Institutional Trust, an estimated $926K sold.
Based on aggregated 13F filings for Q1 2014.